Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Early research (Phase 1)Ended earlyNCT03924245What this trial is testingOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersWho this might be right forFallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03348631What this trial is testingTazemetostat in Treating Patients With Recurrent Ovarian or Endometrial CancerWho this might be right forRecurrent Endometrial Endometrioid AdenocarcinomaRecurrent Malignant Uterine Corpus NeoplasmRecurrent Ovarian Carcinoma+2 more National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Ended earlyNCT05001282What this trial is testingEvaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more Elucida Oncology 79
Early research (Phase 1)Ended earlyNCT04272034What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+15 more Incyte Corporation 105
Early research (Phase 1)Looking for participantsNCT06270706What this trial is testingPLN-101095 in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumor Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Looking for participantsNCT05231122What this trial is testingPembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian CancerWho this might be right forOvarian Clear Cell AdenocarcinomaPlatinum-Sensitive Ovarian CarcinomaRecurrent Endometrial Serous Adenocarcinoma+12 more Roswell Park Cancer Institute 80
Testing effectiveness (Phase 2)Ended earlyNCT02059265What this trial is testingDasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more National Cancer Institute (NCI) 35
Early research (Phase 1)Active Not RecruitingNCT04092270What this trial is testingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian CancerWho this might be right forEndometrial High Grade Endometrioid AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+26 more National Cancer Institute (NCI) 54
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Testing effectiveness (Phase 2)Looking for participantsNCT06023862What this trial is testingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Who this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more Yonsei University 198
Early research (Phase 1)Study completedNCT02020707What this trial is testingNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersWho this might be right forCervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more Mayo Clinic 43
Testing effectiveness (Phase 2)Study completedNCT01935934What this trial is testingCabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more National Cancer Institute (NCI) 102
Large-scale testing (Phase 3)Study completedNCT00002641What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT04065269What this trial is testingATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no LossWho this might be right forGynaecological Cancers Institute of Cancer Research, United Kingdom 174
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Large-scale testing (Phase 3)Study completedNCT00002764What this trial is testingSurgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerMetastatic Cancer+3 more European Organisation for Research and Treatment of Cancer - EORTC 340
Early research (Phase 1)Study completedNCT01440998What this trial is testingDasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Looking for participantsNCT05112601What this trial is testingTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated Carcinoma+6 more National Cancer Institute (NCI) 81
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group